e.steiner
TL2 Moderator · Vaasa
Contributes reviews on supplier material. Based in Vaasa.
Joined 26 October 2024 · last posted 22h
93 posts, newest first. Showing up to 150.
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #28 · Analytics › Home & field testing · 27 Jul 2026 · 1 like Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #86 · Analytics › Home & field testing · 24 Jul 2026 · 28 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #101 · Access › International · 22 Jul 2026 · 2 likes post #100 is right about the mechanism and I think understates the practical bit. Import rules for personal use: what you can import for personal use depends on your…
-
Restarting after a long gap: what the labelling implies Replied, post #34 · Practice › Dosing & titration · 20 Jul 2026 · 0 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Follow-up: Signs of dehydration worth acting on Replied, post #24 · Safety › Adverse events · 14 Jul 2026 · 20 likes Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory agency in your country can help with signal detection across the…
-
What I would want from a home test that does not exist yet Replied, post #27 · Analytics › Home & field testing · 4 Jul 2026 · 32 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #5 · Evidence › Study critique · 1 Jul 2026 · 0 likes post #4 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
What steady state means for the decision to escalate Replied, post #20 · Practice › Dosing & titration · 28 Jun 2026 · 6 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Racemisation and why it is invisible to a mass measurement Replied, post #128 · Analytics › Impurities & related substances · 15 Jun 2026 · 14 likes post #127 answers the question as asked. The question underneath it is different. Related substances: compounds chemically related to the target peptide but not the…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #9 · Compounds › Cagrilintide & amylin analogues · 15 Jun 2026 · 10 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #11 · Outcomes › Body composition · 9 Jun 2026 · 0 likes Precision versus accuracy: the precision you need depends on what question you are answering. "Am I losing fat?" requires less precision than "Is my lean mass…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #14 · Compounds › Oral incretins · 25 May 2026 · 3 likes Coming back to post #12, because the follow-up matters more than the original answer. Fasting instructions are not optional advice. Taking the tablet with food or with…
-
Research-use-only status: what it means legally and practically Replied, post #47 · Compounds › Other compounds · 24 May 2026 · 29 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #7 · Analytics › Home & field testing · 23 Apr 2026 · 25 likes post #6 is right about the mechanism and I think understates the practical bit. What you can use home tests for: confirmation that a solution contains peptide (as…
-
The "under review" status pill and when a moderator applies it Replied, post #78 · Evidence › Preprints · 17 Apr 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #80 · Practice › Interactions · 9 Apr 2026 · 8 likes post #79 is right about the mechanism and I think understates the practical bit. Oral medications versus time: if you take an oral medication 30 minutes before…
-
Transporting a vial for a weekend away — a second dataset Replied, post #23 · Practice › Storage & stability · 8 Apr 2026 · 30 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #24 · Evidence › Journal club · 7 Apr 2026 · 0 likes post #23 answers the question as asked. The question underneath it is different. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #32 · Practice › Administration · 3 Apr 2026 · 6 likes Coming back to post #30, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Personal import allowances, compared — a second dataset Replied, post #97 · Access › International · 3 Apr 2026 · 14 likes Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #60 · Research Methods › N-of-1 designs · 31 Mar 2026 · 11 likes I read post #58 twice before replying, because I had assumed the opposite. Objective versus subjective measures: subjective measures (how you feel) are vulnerable to…
-
Reading an interaction checker output critically Replied, post #138 · Practice › Interactions · 6 Mar 2026 · 27 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Revisiting: Maintainer handover: how it works Replied, post #4 · Meta › Wiki maintenance · 17 Feb 2026 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Specification in the result column: why that is a meaningful error Replied, post #117 · Analytics › COA interpretation · 5 Feb 2026 · 5 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #64 · Sourcing › Red flags · 25 Jan 2026 · 22 likes post #63 is right about the mechanism and I think understates the practical bit. Safety documentation absent: a supplier that cannot provide information about sterility…
-
Residual solvents and scavengers: what is looked for — what changed since Started this topic · Analytics › Impurities & related substances · 16 Jan 2026 · 0 likes Residual solvents and scavengers: what is looked for — what changed since — setting out what I have, and where I think it stops being reliable. Posting the method…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #39 · Practice › Side effects · 16 Jan 2026 · 1 like Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Preprint servers and what screening they do Replied, post #24 · Evidence › Preprints · 14 Jan 2026 · 0 likes post #23 answers the question as asked. The question underneath it is different. Unrefereed work is not worthless. A great deal of it survives review substantially…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #53 · Access › International · 13 Jan 2026 · 0 likes Worth separating two things that post #49 runs together. Country-by-country legality: compound approval and legal status differ substantially by jurisdiction.…
-
Why "add 2 mL" is not an instruction Replied, post #27 · Practice › Reconstitution · 10 Jan 2026 · 11 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #54 · Practice › Side effects · 28 Dec 2025 · 6 likes Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #12 · Research Methods › N-of-1 designs · 19 Dec 2025 · 6 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #39 · Documentation › Doc review · 13 Dec 2025 · 8 likes post #38 is right about the mechanism and I think understates the practical bit. Review date disputes: if a maintained page's review date is approaching and it has not…
-
Substitution between formats during a shortage Replied, post #106 · Access › Shortages · 30 Nov 2025 · 11 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
Cost per delivered dose, which is the number that matters Replied, post #25 · Access › Pricing · 26 Nov 2025 · 29 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
-
The headache that turns out to be dehydration Replied, post #70 · Nutrition & Training › Hydration & electrolytes · 25 Nov 2025 · 5 likes post #69 answers the question as asked. The question underneath it is different. Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods…
-
How to read a forest plot, properly, from scratch Replied, post #58 · Evidence › Trials · 20 Nov 2025 · 0 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #13 · Sourcing › Independent verification · 14 Nov 2025 · 27 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Reconciling a label claim with a content assay Replied, post #4 · Analytics › COA interpretation · 13 Nov 2025 · 26 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #87 · Start Here › How to Ask · 12 Nov 2025 · 7 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #82 · Safety › Adverse events · 2 Nov 2025 · 10 likes Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory agency in your country can help with signal detection across the…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #23 · Clinical › Special populations · 1 Nov 2025 · 4 likes Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #61 · Safety › Adverse events · 27 Oct 2025 · 1 like Acute kidney injury: rare but reported. Symptoms (decreased urine output, creatinine elevation) warrant urgent evaluation. Severe dehydration during weight loss is a…
-
An orphaned page with no inbound links — the long version Replied, post #16 · Meta › Wiki maintenance · 11 Oct 2025 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #78 · Lounge › Off topic · 6 Oct 2025 · 0 likes This follows post #75 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #96 · Analytics › HPLC & UHPLC · 6 Oct 2025 · 27 likes This follows post #93 rather than contradicting it. Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #55 · Compounds › Secretagogues & GH axis · 3 Oct 2025 · 12 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
-
A preprint whose numbers changed substantially at publication — what changed since Replied, post #4 · Evidence › Preprints · 1 Oct 2025 · 0 likes On post #3 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you…
-
GIP receptor agonism and the argument about direction Replied, post #3 · Pharmacology › Receptor biology · 25 Sep 2025 · 2 likes On the opening post — agreed on the reasoning, with one qualification. Species differences: rodent studies show the same compounds produce effects in rodents that…
-
Specification in the result column: why that is a meaningful error Replied, post #45 · Analytics › COA interpretation · 16 Sep 2025 · 10 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #109 · Evidence › Study critique · 16 Sep 2025 · 4 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #116 · Data & Tools › Datasets · 10 Sep 2025 · 7 likes post #115 answers the question as asked. The question underneath it is different. Privacy: if contributing data, only share data you are comfortable making permanent…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #52 · Evidence › Journal club · 13 Aug 2025 · 0 likes Worth separating two things that post #48 runs together. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not…
-
Travel coolers and how long they really hold Replied, post #60 · Devices › Cold chain · 6 Aug 2025 · 5 likes Travel with medication: carrying a vial across borders requires planning if temperatures will exceed the range or if journey time is long. Insulated travel cases with…
-
What this community means by "a source", in practical terms Replied, post #55 · Start Here › Welcome · 1 Aug 2025 · 0 likes On post #51 — agreed on the reasoning, with one qualification. The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive…
-
Coming back to: Official shortage notices and what they authorise Replied, post #50 · Access › Shortages · 7 Jul 2025 · 13 likes Picking up post #47: that is the part I would want checked first. Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is…
-
Why plausible mechanism is not evidence of effect — one year on Replied, post #7 · Compounds › Repair & healing peptides · 26 Jun 2025 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Repeatability versus intermediate precision Replied, post #46 · Analytics › Method validation · 23 Jun 2025 · 0 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #145 · Compounds › Cagrilintide & amylin analogues · 19 Jun 2025 · 0 likes post #144 answers the question as asked. The question underneath it is different. What is genuinely unknown about long-term amylin agonism: real-world response rates,…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #25 · Research Methods › N-of-1 designs · 19 May 2025 · 15 likes Worth separating two things that post #21 runs together. Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #12 · Practice › Reconstitution · 15 May 2025 · 0 likes Worth separating two things that post #8 runs together. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #26 · Outcomes › Body composition · 10 May 2025 · 7 likes Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
Metformin co-administration and additive GI effects Replied, post #15 · Practice › Interactions · 26 Apr 2025 · 2 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
An orphaned page with no inbound links Replied, post #32 · Meta › Wiki maintenance · 24 Apr 2025 · 21 likes Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned. Such pages should either be linked or deprecated.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #47 · Evidence › Journal club · 19 Apr 2025 · 14 likes post #46 answers the question as asked. The question underneath it is different. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight…
-
Certificates issued by the seller versus by a laboratory Replied, post #42 · Analytics › COA interpretation · 12 Apr 2025 · 2 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #17 · Evidence › Journal club · 1 Apr 2025 · 0 likes I read post #15 twice before replying, because I had assumed the opposite. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the…
-
Fibre intake when total intake falls, and the constipation link Replied, post #41 · Nutrition & Training › Protein & intake · 17 Mar 2025 · 2 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #37 · Compounds › Tirzepatide · 11 Mar 2025 · 4 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #124 · Compounds › Semaglutide · 9 Mar 2025 · 0 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #78 · Compounds › Semaglutide · 26 Feb 2025 · 5 likes post #77 answers the question as asked. The question underneath it is different. The SELECT trial changed the positioning because it was the first cardiovascular…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #50 · Sourcing › Red flags · 9 Feb 2025 · 13 likes On post #46 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Consistent declarations and why they matter more than clever ones Replied, post #12 · Sourcing › Logistics · 9 Feb 2025 · 25 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What we do not know about retatrutide, listed explicitly Replied, post #79 · Compounds › Retatrutide · 2 Feb 2025 · 28 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
UK access routes, dated and sourced — a second dataset Replied, post #29 · Regional › UK & Ireland · 21 Jan 2025 · 2 likes This follows post #26 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Follow-up: Individual participant data versus aggregate data Replied, post #19 · Evidence › Meta-analyses · 8 Jan 2025 · 9 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #95 · Devices › Syringes & needles · 6 Jan 2025 · 23 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
-
Isotope patterns and why the monoisotopic peak is not the tallest Replied, post #8 · Analytics › Mass spectrometry · 28 Dec 2024 · 0 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #10 · Analytics › Mass spectrometry · 24 Dec 2024 · 0 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #85 · Compounds › Semaglutide · 24 Dec 2024 · 2 likes post #84 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #74 · Devices › Syringes & needles · 30 Nov 2024 · 27 likes I read post #72 twice before replying, because I had assumed the opposite. Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are…
-
Follow-up: Recovery when intake is low: what to cut first Replied, post #33 · Nutrition & Training › Resistance training · 20 Nov 2024 · 25 likes I read post #31 twice before replying, because I had assumed the opposite. Cardio and resistance: the interaction between energy-intense cardiovascular training and…
-
Why "any advice?" is the least effective ending for a post Replied, post #46 · Start Here › How to Ask · 17 Nov 2024 · 0 likes post #45 answers the question as asked. The question underneath it is different. Chromatogram questions: describe the method first. Column type, gradient, wavelength,…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #33 · Evidence › Journal club · 15 Nov 2024 · 0 likes post #32 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Time to steady state after a dose increase Replied, post #86 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 29 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
Why "any advice?" is the least effective ending for a post Replied, post #4 · Start Here › How to Ask · 2 Nov 2024 · 0 likes post #2 answers the question as asked. The question underneath it is different. Avoid "any advice?" at the end. It is so generic that people do not know which part of…
-
Converting between mg/mL and units per dose, both directions Replied, post #49 · Practice › Reconstitution · 13 Oct 2024 · 13 likes post #48 answers the question as asked. The question underneath it is different. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #26 · Wellbeing › Mental health · 11 Oct 2024 · 1 like Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift thinking about body and substance use. This is a risk factor…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #14 · Evidence › Journal club · 10 Aug 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Journal club: FLOW and the renal composite, component by component Replied, post #85 · Evidence › Journal club · 17 Jul 2024 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Journal club: FLOW and the renal composite, component by component Replied, post #64 · Evidence › Journal club · 15 Jul 2024 · 12 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Cold packs, phase-change material, and what survives ten days Replied, post #79 · Sourcing › Logistics · 7 Jul 2024 · 20 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
How this community labels and discusses unrefereed work Replied, post #29 · Evidence › Preprints · 20 Jun 2024 · 18 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…